Search Results - A. S. Semashko

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
    Pathophysiology of iron and hepcidin metabolism: research perspectives in rheumatolog

    Pathophysiology of iron and hepcidin metabolism: research perspectives in rheumatolog by A. M. Lila, E. A. Galushko, A. S. Semashko

    Published 2022-11-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    The clinical significance of iron metabolism disorders in patients with high activity of rheumatoid arthritis

    The clinical significance of iron metabolism disorders in patients with high activity of rheumatoid arthritis by E. A. Galushko, A. S. Semashko, A. M. Lila

    Published 2024-06-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Early arthritis as a rheumatological chameleon: a description of a clinical case

    Early arthritis as a rheumatological chameleon: a description of a clinical case by E. A. Galushko, A. V. Alekseeva, G. V. Serikova, A. S. Semashko

    Published 2021-10-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    The role of microbiome in the pathogenesis of immune-mediated inflammatory diseases: controversial issues

    The role of microbiome in the pathogenesis of immune-mediated inflammatory diseases: controversial issues by A. M. Lila, E. A. Galushko, A. V. Gordeev, A. S. Semashko

    Published 2021-02-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    The use of anakinra in a patient with gout and long-term follow-up of rheumatoid arthritis

    The use of anakinra in a patient with gout and long-term follow-up of rheumatoid arthritis by E. V. Cheremushkina, M. S. Eliseev, A. S. Semashko, A. V. Alekseeva, A. M. Lila

    Published 2023-07-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    The use of hepcidin as a marker for diagnosing the type of anemia in patients with high activity of rheumatoid arthritis

    The use of hepcidin as a marker for diagnosing the type of anemia in patients with high activity of rheumatoid arthritis by A. S. Semashko, A. M. Lila, E. A. Galushko, A. V. Gordeev, E. G. Zotkin

    Published 2023-12-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    Assessing the multimorbid profile (CIRS) in rheumatoid arthritis. First results

    Assessing the multimorbid profile (CIRS) in rheumatoid arthritis. First results by A. V. Gordeev, E. A. Galushko, N. M. Savushkina, N. V. Demidova, A. S. Semashko

    Published 2019-09-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Dynamics of patient reported outcomes during the use various biological disease-modifying antirheumatic drugs for rheumatoid arthritis

    Dynamics of patient reported outcomes during the use various biological disease-modifying antirheumatic drugs for rheumatoid arthritis by A. E. Karateev, A. M. Lila, T. S. Panevin, A. S. Potapova, A. S. Semashko, A. O. Bobkova, V. N. Amirjanova, E. G. Zotkin

    Published 2022-09-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    Dynamics of traditional modifiable risk factors, total cardiovascular risk, and structural changes of carotid arteries in patients with rheumatoid arthritis on long-term interleukin-6 receptor antagonist treatment

    Dynamics of traditional modifiable risk factors, total cardiovascular risk, and structural changes of carotid arteries in patients with rheumatoid arthritis on long-term interleuki... by E. V. Gerasimova, T. V. Popkova, A. V. Martynova, I. G. Kirillova, E. I. Markelova, A. S. Semashko, A. M. Lila, E. L. Nasonov

    Published 2021-03-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    T- and B-lymphocytes subpopulations in the early and advanced rheumatoid arthritis

    T- and B-lymphocytes subpopulations in the early and advanced rheumatoid arthritis by A. V. Martynova, T. V. Popkova, A. P. Aleksankin, G. I. Gridneva, E. V. Gerasimova, Yu. N. Gorbunova, A. S. Semashko, A. M. Lila

    Published 2021-04-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    Features of clinical manifestations of rheumatoid arthritis in patients after failure of conventional synthetic disease-modifying antirheumatic drugs therapy depending on the signs of central sensitization

    Features of clinical manifestations of rheumatoid arthritis in patients after failure of conventional synthetic disease-modifying antirheumatic drugs therapy depending on the signs... by A. S. Potapova, A. E. Karateev, E. Yu. Polishchuk, E. V. Matyanova, T. S. Panevin, A. S. Semashko, A. O. Bobkova, A. R. Khalmetova, E. S. Filatova, V. N. Amirjanova, A. M. Lila

    Published 2023-04-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    The use of biological disease-modifying antirheumatic drugs and Janus kinase inhibitors in rheumatoid arthritis during the COVID-19 coronavirus disease pandemic: data from a telephone survey of 254 patients

    The use of biological disease-modifying antirheumatic drugs and Janus kinase inhibitors in rheumatoid arthritis during the COVID-19 coronavirus disease pandemic: data from a teleph... by A. E. Karateev, E. Yu. Polishchuk, A. S. Potapova, E. V. Matyanova, A. S. Semashko, А. O. Bobkova, E. S. Filatova, V. N. Amirjanova, S. I. Glukhova, E. G. Zotkin, A. M. Lila

    Published 2022-05-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: